๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical significance of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in transitional cell cancer

โœ Scribed by Yasuhiro Hirano; Shinji Kageyama; Tomomi Ushiyama; Kazuo Suzuki; Kimio Fujita


Publisher
Springer
Year
2003
Tongue
English
Weight
246 KB
Volume
51
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Thymidine phosphorylase and dihydropyrim
โœ Elaina S.R. Collie-Duguid; Stephen J. Johnston; Linda Boyce; Nicola Smith; Aaron ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 96 KB

It is essential for actively proliferating cells to increase their rate of DNA synthesis to progress through the cell cycle. This is reflected in the increased uracil usage that is a common feature in solid tumours. Thymidine phosphorylase (TP) anabolises formation of pyrimidine nucleosides availabl

The predictive and therapeutic value of
โœ Koichiro Saito; Khurram Khan; Shu-Zhen Yu; Steve Ronson; Joung Rhee; Gouyan Li; ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 440 KB

## Abstract ## Objectives: To evaluate whether two molecular biomarkers, thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD), could be clinically useful in predicting and improving the chemotherapeutic outcome of the oral fluoropyrimidine capecitabine (5โ€ฒโ€DFUR or Xelodaยฎ), in th